← Back to directory

Jan Starý

Researcher Next ID · RN-041672

Researcher · Medicine

Charles University

Prague, Czechia

Accepting doctoral researchersFunding unknown
Works count
910
Citation count
16,317
H-index
67
i10-index
234

Research interests

Medicine
Acute Lymphoblastic Leukemia research
Acute Myeloid Leukemia Research
Chronic Myeloid Leukemia Treatments
Childhood Cancer Survivors' Quality of Life
Lymphoma Diagnosis and Treatment

Publications

  • Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study

    Journal of Clinical Oncology · 2019 · https://doi.org/10.1200/jco.19.00261

  • Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents

    Blood · 2015 · https://doi.org/10.1182/blood-2015-09-669937

  • Intensive Chemotherapy for Childhood Acute Lymphoblastic Leukemia: Results of the Randomized Intercontinental Trial ALL IC-BFM 2002

    Journal of Clinical Oncology · 2013 · 10.1200/jco.2013.48.6522

  • Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004

    Blood · 2013 · https://doi.org/10.1182/blood-2013-02-484097

  • Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study

    The Lancet Oncology · 2012 · 10.1016/s1470-2045(12)70377-7

  • Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel

    Blood · 2012 · https://doi.org/10.1182/blood-2012-03-362608

  • Improved outcome with hematopoietic stem cell transplantation in a poor prognostic subgroup of infants with mixed-lineage-leukemia (MLL)–rearranged acute lymphoblastic leukemia: results from the Interfant-99 Study

    Blood · 2010 · https://doi.org/10.1182/blood-2010-03-273532

  • Prognostic Impact of Specific Chromosomal Aberrations in a Large Group of Pediatric Patients With Acute Myeloid Leukemia Treated Uniformly According to Trial AML-BFM 98

    Journal of Clinical Oncology · 2010 · https://doi.org/10.1200/jco.2009.25.6321

  • Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia

    Nature Genetics · 2010 · https://doi.org/10.1038/ng.641

  • Standardized MRD quantification in European ALL trials: Proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18–20 September 2008

    Leukemia · 2009 · https://doi.org/10.1038/leu.2009.268

  • Mutations in CBL occur frequently in juvenile myelomonocytic leukemia

    Blood · 2009 · https://doi.org/10.1182/blood-2009-01-198416

  • Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study

    Blood · 2009 · https://doi.org/10.1182/blood-2009-04-215152

  • A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial

    The Lancet · 2007 · https://doi.org/10.1016/s0140-6736(07)61126-x

  • Less Toxicity by Optimizing Chemotherapy, but Not by Addition of Granulocyte Colony-Stimulating Factor in Children and Adolescents With Acute Myeloid Leukemia: Results of AML-BFM 98

    Journal of Clinical Oncology · 2006 · https://doi.org/10.1200/jco.2006.06.5037

  • AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity

    Leukemia · 2005 · https://doi.org/10.1038/sj.leu.2403814

  • Early Deaths and Treatment-Related Mortality in Children Undergoing Therapy for Acute Myeloid Leukemia: Analysis of the Multicenter Clinical Trials AML-BFM 93 and AML-BFM 98

    Journal of Clinical Oncology · 2004 · https://doi.org/10.1200/jco.2004.01.191

Current projects

    No projects listed.